We are live on ! Find out more
P

&Partners Portfolio holdings

AUM $20.2B
1-Year Est. Return 19.79%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+19.79%
3 Year Est. Return
+62.7%
5 Year Est. Return
+67.16%
10 Year Est. Return
AUM
$2.28B
AUM Growth
+$1.56B
Cap. Flow
+$1.51B
Cap. Flow %
66.23%
Top 10 Hldgs %
23.13%
Holding
926
New
435
Increased
440
Reduced
23
Closed
12

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$66.8M
2
AAPL icon
Apple
AAPL
+$54.9M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$50.4M
4
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$32.9M
5
NVDA icon
NVIDIA
NVDA
+$29.1M

Sector Composition

Rank Sector Weight
1 Technology 17.11%
2 Financials 7.61%
3 Healthcare 6.47%
4 Industrials 5.45%
5 Consumer Discretionary 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGGR icon
26
Capital Group Growth ETF
CGGR
$23.5B
$14.7M 0.64%
445,461
+13,588
+3% +$431K
COST icon
27
Costco
COST
$415B
$14.4M 0.63%
16,917
+13,114
+345% +$10.2M
CVX icon
28
Chevron
CVX
$388B
$14M 0.61%
89,836
+67,144
+296% +$10.7M
UNH icon
29
UnitedHealth
UNH
$382B
$13.6M 0.59%
26,616
+21,812
+454% +$10.7M
META icon
30
Meta Platforms (Facebook)
META
$1.51T
$13.2M 0.58%
26,111
+18,652
+250% +$9.07M
ADI icon
31
Analog Devices
ADI
$181B
$13M 0.57%
57,067
+51,545
+933% +$11M
WMT icon
32
Walmart Inc
WMT
$871B
$12.9M 0.56%
189,760
+104,495
+123% +$6.58M
AMGN icon
33
Amgen
AMGN
$203B
$12.8M 0.56%
40,879
+31,824
+351% +$9.35M
BLK icon
34
Blackrock
BLK
$164B
$12.7M 0.56%
16,189
+13,572
+519% +$10.6M
FBCG icon
35
Fidelity Blue Chip Growth ETF
FBCG
$6.76B
$12.6M 0.55%
296,061
+24
+0% +$948
PEP icon
36
PepsiCo
PEP
$186B
$12.4M 0.54%
75,210
+62,794
+506% +$10.8M
AFL icon
37
Aflac
AFL
$63.9B
$12.3M 0.54%
137,125
+117,759
+608% +$10.1M
VUG icon
38
Vanguard Growth ETF
VUG
$216B
$12.2M 0.53%
195,078
+123,138
+171% +$7.18M
VEA icon
39
Vanguard FTSE Developed Markets ETF
VEA
$226B
$12.1M 0.53%
245,445
+206,092
+524% +$10.3M
XOM icon
40
ExxonMobil
XOM
$651B
$11.8M 0.52%
102,843
+59,644
+138% +$6.95M
ACN icon
41
Accenture
ACN
$89.9B
$11.5M 0.5%
37,846
+34,395
+997% +$10.5M
MCD icon
42
McDonald's
MCD
$188B
$11.4M 0.5%
44,760
+34,300
+328% +$9.1M
DGRO icon
43
iShares Core Dividend Growth ETF
DGRO
$42.6B
$11.3M 0.5%
196,544
+133,258
+211% +$7.61M
MRK icon
44
Merck
MRK
$324B
$11.3M 0.49%
91,226
+62,947
+223% +$8.11M
ABT icon
45
Abbott
ABT
$180B
$11.2M 0.49%
107,790
+84,950
+372% +$9.01M
GD icon
46
General Dynamics
GD
$105B
$11.2M 0.49%
38,471
+33,449
+666% +$9.8M
VEU icon
47
Vanguard FTSE All-World ex-US ETF
VEU
$65.6B
$11M 0.48%
188,254
+10,497
+6% +$616K
ADP icon
48
Automatic Data Processing
ADP
$100B
$11M 0.48%
45,925
+39,746
+643% +$9.76M
OUSA icon
49
ALPS O'Shares U.S. Quality Dividend ETF
OUSA
$737M
$10.9M 0.48%
+218,762
New +$10.6M
NEE icon
50
NextEra Energy
NEE
$187B
$10.5M 0.46%
148,096
+118,391
+399% +$8.4M

Similar funds

&Partners's Q2 2024 Portfolio in Review

As of Q2 2024, &Partners held 926 positions worth $2.28B, up 215% from $726M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

&Partners deployed $1.51B of net new capital in Q2 2024, opening 435 new positions and adding to 440 existing holdings. Its largest new stake was ALPS O'Shares U.S. Quality Dividend ETF: 218,762 shares worth $10.9M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Vanguard Large-Cap ETF, an estimated $10M trimmed.

  • &Partners's largest Q2 2024 buy was ALPS O'Shares U.S. Quality Dividend ETF: 218,762 shares worth $10.9M.
  • &Partners added most to Microsoft in Q2 2024, an estimated $66.8M increase.
  • &Partners's biggest Q2 2024 reduction was Vanguard Large-Cap ETF, cutting an estimated $10M.
  • &Partners fully exited Darling Ingredients in Q2 2024, selling an estimated $390K.
  • &Partners's ten largest holdings make up 23% of its $2.28B portfolio in Q2 2024.
  • &Partners opened 435 new positions and closed 12 in Q2 2024.
  • &Partners's portfolio value rose 215% quarter-over-quarter to $2.28B.

Based on &Partners's 13F filing for Q2 2024, filed 24 Jul 2024.